 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: BRIUMVI (ublituximab) |
|
***************************************************** |
|
#Post#: 3335-------------------------------------------------- |
|
Ublituximab "reassuring" as potential relapsing MS the |
|
rapy |
|
By: agate Date: June 30, 2021, 6:47 pm |
|
--------------------------------------------------------- |
|
From Multiple Sclerosis News Today (June 30, 2021)--"Ublituximab |
|
'Quite Reassuring' as Potential RMS Therapy, Experts Say": |
|
https://multiplesclerosisnewstoday.com/news-posts/2021/06/30/ublituximab-tg-the… |
|
#Post#: 3424-------------------------------------------------- |
|
Ublituximab up for FDA approval |
|
By: agate Date: October 2, 2021, 1:04 am |
|
--------------------------------------------------------- |
|
From Multiple Sclerosis News Today (October 1, |
|
2021)--"Ublituximab, Potential Relapsing MS Therapy, Up for FDA |
|
Approval": |
|
https://multiplesclerosisnewstoday.com/news-posts/2021/10/01/tg-therapeutics-as… |
|
#Post#: 3687-------------------------------------------------- |
|
(CMSC) Ubilituximab tied to slowed disease progression in relaps |
|
ing MS |
|
By: agate Date: June 18, 2022, 1:19 am |
|
--------------------------------------------------------- |
|
From Medscape Today (June 10, 2022)--"Novel drug tied to slowed |
|
disease progression in relapsing MS": |
|
https://www.medscape.com/viewarticle/975368 |
|
#Post#: 3755-------------------------------------------------- |
|
(Abst.) Ublituximab vs. teriflunomide in relapsing MS |
|
By: agate Date: August 27, 2022, 1:35 am |
|
--------------------------------------------------------- |
|
From PubMed (August 25, 2022), citing a New England Journal of |
|
Medicine article, "Ublituximab versus teriflunomide in relapsing |
|
multiple sclerosis": |
|
https://pubmed.ncbi.nlm.nih.gov/36001711/ |
|
***************************************************** |
